event,time
56 years old ,0
    male ,0
    admitted to ICU ,0
    diabetes mellitus ,-336
    hypertension ,-336
    hyperlipidemia ,-336
    obesity ,-336
    BMI 31 kg/m² ,0
    antihypertensive therapy ,-336
    angiotensin II receptor blockers ,-336
    calcium channel blockers ,-336
    metformin ,-336
    glimepiride ,-336
    atorvastatin ,-336
    inhaled fluticasone propionate/salmeterol ,-336
    COPD suspicion ,-336
    intermittent fever ,-336
    muscle ache ,-336
    nonproductive cough ,-168
    progressively increasing dyspnea ,-168
    amoxicillin treatment ,-192
    pristinamycin treatment ,-120
    heart rate 99 beats/min ,0
    respiratory rate 34 breaths/min ,0
    blood pressure 132/92 mmHg ,0
    temperature 38°C ,0
    oxygen saturation 95% ,0
    arterial blood gas pH 7.41 ,0
    pCO2 27.9 mmHg ,0
    pO2 87.9 mmHg ,0
    PaO2/FiO2 87.9 ,0
    white blood cell count 10720 cells/mm³ ,0
    neutrophils 82.6% ,0
    lymphocytes 12.7% ,0
    lactate dehydrogenase 882 U/L ,0
    CRP 206 mg/dL ,0
    ferritin 556 ng/mL ,0
    D-dimer 2390 ng/mL ,0
    interleukin-6 93.6 pg/mL ,0
    SOFA score 8 ,0
    hypoxemic respiratory failure ,0
    mechanical ventilation ,0
    norepinephrine ,0
    diabetic ketoacidosis ,0
    pH 7.3 ,0
    glucose 20.5 mmol/L ,0
    ketonemia ,0
    bicarbonate ions 17.2 mmol/L ,0
    continuous insulin infusion ,0
    acute kidney failure ,0
    creatinine 2.76 mg/dL ,0
    chest CT bilateral ground-glass opacities ,0
    pulmonary nodules ,0
    SARS-CoV-2 PCR positive ,0
    dexamethasone treatment ,48
    eculizumab infusion ,48
    piperacillin-tazobactam ,-168
    cefotaxime ,-168
    spiramycin ,-168
    tracheal aspirate BioFire negative ,96
    serum galactomannan negative ,0
    serum β-D-Glucan negative ,0
    worsening condition ,144
    increased vasopressor need ,144
    increased oxygen need ,144
    tracheal aspirate branching hyphae ,144
    culture A. fumigatus ,144
    Af qPCR positive ,144
    bacterial culture negative ,144
    transthoracic echocardiogram hypertrophy ,144
    right ventricle dilation ,144
    D-dimer >20000 ng/mL ,144
    fibrinogen 3.85 g/L ,144
    cardiac arrest ,144
    death ,144
    posaconazole MIC 0.5 µg/mL ,144
    itraconazole MIC >8 µg/mL ,144
    voriconazole MIC 2 µg/mL ,144
    isavuconazole MIC 4 µg/mL ,144
    cyp51A TR34/L98H mutation ,144
